290 related articles for article (PubMed ID: 22834080)
21. Electrospun nanofibers in oral drug delivery.
Ignatious F; Sun L; Lee CP; Baldoni J
Pharm Res; 2010 Apr; 27(4):576-88. PubMed ID: 20143253
[TBL] [Abstract][Full Text] [Related]
22. Oral fast-release solid dispersion-paradigm shift to nanoparticles.
Wong TW
Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):227-43. PubMed ID: 21834774
[TBL] [Abstract][Full Text] [Related]
23. Electrospinning of polymeric nanofibers for drug delivery applications.
Hu X; Liu S; Zhou G; Huang Y; Xie Z; Jing X
J Control Release; 2014 Jul; 185():12-21. PubMed ID: 24768792
[TBL] [Abstract][Full Text] [Related]
24. Electrospun nanofibers for the delivery of active drugs through nasal, oral and vaginal mucosa: Current status and future perspectives.
Sofi HS; Abdal-Hay A; Ivanovski S; Zhang YS; Sheikh FA
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110756. PubMed ID: 32279775
[TBL] [Abstract][Full Text] [Related]
25. [The improvement of poorly water-soluble drug solubility through electrospun drug-loaded nanofibers].
Yu DG; Zhang XF; Shen XX; Branford-White C; Zhu LM
Yao Xue Xue Bao; 2009 Oct; 44(10):1179-82. PubMed ID: 20055145
[TBL] [Abstract][Full Text] [Related]
26. Current strategies for sustaining drug release from electrospun nanofibers.
Chou SF; Carson D; Woodrow KA
J Control Release; 2015 Dec; 220(Pt B):584-91. PubMed ID: 26363300
[TBL] [Abstract][Full Text] [Related]
27. Applicability, Commercial Utility and Recent Patents on Starch and Starch Derivative as Pharmaceutical Drug Delivery Carrier.
Pandey S; Malviya R; Sharma PK
Recent Pat Drug Deliv Formul; 2015; 9(3):249-56. PubMed ID: 26205680
[TBL] [Abstract][Full Text] [Related]
28. Dual drug release from coaxial electrospun nanofibers.
Su Y; Mo X
J Control Release; 2011 Nov; 152 Suppl 1():e82-4. PubMed ID: 22195944
[No Abstract] [Full Text] [Related]
29. Recent advances in protein and peptide drug delivery systems.
Malik DK; Baboota S; Ahuja A; Hasan S; Ali J
Curr Drug Deliv; 2007 Apr; 4(2):141-51. PubMed ID: 17456033
[TBL] [Abstract][Full Text] [Related]
30. Electrospun polymeric nanofibers: New horizons in drug delivery.
Thakkar S; Misra M
Eur J Pharm Sci; 2017 Sep; 107():148-167. PubMed ID: 28690099
[TBL] [Abstract][Full Text] [Related]
31. The 12th Conference on the Formulation and Delivery of Bioactives.
Tucker IG
Ther Deliv; 2010 Jul; 1(1):25-7. PubMed ID: 22816116
[TBL] [Abstract][Full Text] [Related]
32. Hybrid Electrospun Polycaprolactone Mats Consisting of Nanofibers and Microbeads for Extended Release of Dexamethasone.
Hsu KH; Fang SP; Lin CL; Liao YS; Yoon YK; Chauhan A
Pharm Res; 2016 Jun; 33(6):1509-16. PubMed ID: 26975358
[TBL] [Abstract][Full Text] [Related]
33. Advances in recognitive, conductive and responsive delivery systems.
Bayer CL; Peppas NA
J Control Release; 2008 Dec; 132(3):216-21. PubMed ID: 18652857
[TBL] [Abstract][Full Text] [Related]
34. Nanocrystal technology in the delivery of poorly soluble drugs: an overview.
Nagarwal RC; Kumar R; Dhanawat M; Das N; Pandit JK
Curr Drug Deliv; 2011 Jul; 8(4):398-406. PubMed ID: 21453258
[TBL] [Abstract][Full Text] [Related]
35. Nanofibers: An Effective Tool for Controlled and Sustained Drug Delivery.
Singh A; Rath G; Singh R; Goyal AK
Curr Drug Deliv; 2018 Feb; 15(2):155-166. PubMed ID: 28969554
[TBL] [Abstract][Full Text] [Related]
36. Multidimensional targeting: using physical and chemical forces in unison.
Van Lehn RC; Sing CE; Chen H; Alexander-Katz A
Curr Pharm Biotechnol; 2010 Jun; 11(4):320-32. PubMed ID: 20201796
[TBL] [Abstract][Full Text] [Related]
37. Preparation of poloxamer-based nanofibers for enhanced dissolution of carvedilol.
Kajdič S; Vrečer F; Kocbek P
Eur J Pharm Sci; 2018 May; 117():331-340. PubMed ID: 29514051
[TBL] [Abstract][Full Text] [Related]
38. Progress in the study of drug nanocrystals.
Shi J; Guo F; Zheng A; Zhang X; Sun J
Pharmazie; 2015 Dec; 70(12):757-64. PubMed ID: 26817271
[TBL] [Abstract][Full Text] [Related]
39. The potential of nanofibers to increase solubility and dissolution rate of the poorly soluble and chemically unstable drug lovastatin.
Kajdič S; Zupančič Š; Roškar R; Kocbek P
Int J Pharm; 2020 Jan; 573():118809. PubMed ID: 31678525
[TBL] [Abstract][Full Text] [Related]
40. Overview of drug product development.
Narayan P
Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
